Innovating Works

FPO

Desconocido
PERSIST-SEQ: Building a reproducible single cell experimental workflow to capture tumour cell persistence FONDAZIONE DEL PIEMONTE PER LONCOLOGIA participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage It is the ambition of PRESIST-SEQ to provide a new gold standard in single-cell experimental workflows the cancer research community by deve...
2021-06-28 - 2026-06-30 | Financiado
ProCAncer-I: An AI Platform integrating imaging data and models supporting precision care through prostate cance... FONDAZIONE DEL PIEMONTE PER LONCOLOGIA participó en un H2020: H2020-SC1-FA-DTS-2018-2020 In Europe, prostate cancer (PCa) is the second most frequent type of cancer in men and the third most lethal. Current clinical practices, of...
2020-05-29 - 2024-09-30 | Financiado
Instand-NGS4P: Integrated and standardized NGS workflows for Personalised therapy FONDAZIONE DEL PIEMONTE PER LONCOLOGIA participó en un H2020: H2020-SC1-BHC-2018-2020 Instand-NGS4P is a 65-month PCP project federating 7 leading medical centers (two are coordinating ERNs) as buyers’ group with major experie...
2019-12-13 - 2025-05-31 | Financiado
MDCRC: Metabolic Dynamics in Colorectal Cancer FONDAZIONE DEL PIEMONTE PER LONCOLOGIA tramitó un H2020: H2020-MSCA-IF-2017 Metabolic reprogramming has recently emerged as a key hallmark of cancer. Despite many efforts made to identify metabolic properties of canc...
2018-04-04 - 2020-07-19 | Financiado
RESTORATION: Resorbable Ceramic Biocomposites for Orthopaedic and Maxillofacial Applications FONDAZIONE DEL PIEMONTE PER LONCOLOGIA participó en un FP7: Ceramic composite materials have for many years been considered to show great promise in the repair of musculoskeletal defects. The materia...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.